代谢不稳定的酸赋予不可逆转的抑制剂运动选择性
Balyn W Zaro1, Landon R Whitby1, Kenneth M Lum1
1The Skaggs Institute for Chemical Biology and Department of Chemical Physiology , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Journal of the American Chemical Society
|December 15, 2016
概括
研究人员开发了一种策略,通过使其具有代谢不稳定性来提高电友药物的精度. 这种方法增强了运动选择性,使得针对性蛋白质的修饰能够改善化学探针和治疗方法.
科学领域:
- 医学化学
- 化学生物学
- 药理学
背景情况:
- 电友小分子作为化学探针和药物至关重要,通常通过不可逆转的蛋白质修饰起作用.
- 性药物,如用于癌症的激酶抑制剂和用于多发性硬化症的二甲基烟酸,是这一类药物的例子.
- 一个关键的挑战是时间依赖的,非目标修改的可能性,这可能会降低选择性和效用.
研究的目的:
- 开发一种方法,使电友药物具有运动选择性.
- 提高共价药物和化学探测器的精度.
- 在保持目标接触的同时减轻目标外反应.
主要方法:
- 改性共价布鲁顿氨酸激酶 (BTK) 抑制剂易布鲁替尼的设计和合成,其中包含一种代谢不稳定的 fumarate ester 电.
- 修改后的抑制剂的酶代谢动力学的评估.
- 在细胞和动物模型中评估目标参与和非目标反应性.
主要成果:
- 烟酸类型在相关时间内表现出对酶代谢的脆弱性.
- 这种代谢可变性保持了目标蛋白BTK的快速和持续抑制.
- 在细胞和动物模型中,与非代谢类型相比,非目标反应性显著降低.
结论:
- 可以将代谢不稳定的电友基组战略性地纳入共价药物,以实现动力选择性.
- 这种方法可以精确地扰乱特定的蛋白质和生化途径.
- 这些发现支持开发更有选择性和有效的共价疗法和化学探针.
相关概念视频
Enzyme Inhibition
94.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
94.3K
Regioselective Formation of Enolates
3.6K
As depicted in the figure below, the unsymmetrical ketones can form two possible enolates: less substituted or more substituted enolates. Usually, the thermodynamic enolates are formed from the more substituted α-carbon atom, while the kinetic enolates are formed faster by deprotonation from the less substituted position. The thermodynamic enolates have lower energy, so they are more stable. But the energy required to form kinetic enolates is less.
3.6K
The Electron Transport Chain
20.8K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
20.8K
Carboxylic Acids to Esters: Acid-Catalyzed (Fischer) Esterification Overview
21.1K
The Fischer esterification reaction was developed by the German chemist Emil Fischer in 1895. It is a condensation reaction between carboxylic acids and alcohols in an acidic medium to give esters and water.
21.1K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
893
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
893
Drug Metabolism: Phase II Reactions
5.4K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
5.4K


